| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Human Resources Ofc
1 company
Shannon L. Devers is EVP, Chief Human Resources Ofc at IONS. Shannon L. Devers's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $720K at current prices.
Historically, Shannon L. Devers's trades have earned a middling insider score of 64/100 across 10 rated trades. Over a 12-month horizon, 75.0% of those trades were profitable, with an average 12-month return of -4.0%.
The IONS filings lean toward selling, a net 115,654 shares.
Shannon L. Devers has 14 Form 4 filings on record from September 2024 to October 2026, all as EVP, Chief Human Resources Ofc at Ionis Pharmaceuticals (IONS), 2024–2026.
The 43 reported transactions were 18 option exercises, 17 open-market sales and 8 option or other derivative awards.
Counted by filing, the open-market trades come to no purchases and 10 sales worth about $9.1M.
The largest open-market sale was 44,199 shares of IONS at an average $85.08 on January 7, 2026, about $3.8M.
7 of the 10 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other 3 were not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 2026 | IONS Ionis Pharmaceuticals, Inc. | EVP, Chief Human Resources Ofc | Sale+OE | 1,357 | $43.54 | $59,081.88 | -7.1% | - | - | |
| Apr 2, 2026 | IONS Ionis Pharmaceuticals, Inc. | EVP, Chief Human Resources Ofc | Sell10b5-1 | 6,193 | $74.05 | $458,613.33 | -27.5% | +5.9% | - | |
| Mar 3, 2026 | IONS Ionis Pharmaceuticals, Inc. | EVP, Chief Human Resources Ofc | Sale+OE10b5-1 | 20,106 | $79.40 | $1,596,432.82 | -47.1% | -4.2% | - | |
| Jan 22, 2026 | IONS Ionis Pharmaceuticals, Inc. | EVP, Chief Human Resources Ofc | Sell10b5-1 | 3,977 | $81.34 | $323,490.37 | -15.0% | -8.5% | - | |
| Jan 16, 2026 | IONS Ionis Pharmaceuticals, Inc. | EVP, Chief Human Resources Ofc | Sale+OE | 8,353 | $75.95 | $634,410.35 | -24.0% | -1.4% | - | |
| Jan 7, 2026 | IONS Ionis Pharmaceuticals Inc | EVP, Chief Human Resources Ofc | Sale+OE10b5-1 | 44,199 | $85.08 | $3,760,577.42 | -71.6% | -11.2% | - | |
| Nov 25, 2025 | IONS Ionis Pharmaceuticals Inc | EVP, Chief Human Resources Ofc | Sale+OE10b5-1 | 16,777 | $80.91 | $1,357,442.17 | -49.0% | +4.5% | - | |
| Oct 16, 2025 | IONS Ionis Pharmaceuticals Inc | EVP, Chief Human Resources Ofc | Sale+OE10b5-1 | 7,263 | $73.06 | $530,637.50 | -29.3% | +7.9% | -41.2% | |
| Sep 3, 2025 | IONS Ionis Pharmaceuticals Inc | EVP, Chief Human Resources Ofc | Sale+OE10b5-1 | 3,162 | $61.02 | $192,942.71 | -17.4% | +34.4% | -3.9% | |
| Jan 16, 2025 | IONS Ionis Pharmaceuticals Inc | EVP, Chief Human Resources Ofc | Sale+OE | 4,267 | $32.78 | $139,855.19 | -21.1% | -12.2% | +136.5% |